| Bioactivity | Enzalutamide-d6 is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells[1]. |
| Name | Enzalutamide-d6 |
| CAS | 1443331-94-9 |
| Formula | C21H10D6F4N4O2S |
| Molar Mass | 470.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tran C, et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science. 2009 May 8;324(5928):787-90. |
Enzalutamide-d6
CAS: 1443331-94-9 F: C21H10D6F4N4O2S W: 470.47
Enzalutamide-d6 is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.